The evolution of technology and biomaterials has permitted a parallel development of renal replacement therapies in the acute, critically ill patient. From the original continuous artero-venous hemofiltration method new techniques such as continuous veno-venous hemofiltration, hemodiafiltration and high-flux dialysis have been developed and are clinically used. Similar progress has been made with artificial membranes. We investigated the possibility of using a modified cellulosic membrane for continuous therapies, assessing the hydraulic characteristics and clearance performances of high-flux cellulose triacetate hemodiafilter (0.7 m2) in vitro and in vivo. The flowdynamic characteristics of the filter suggest its optimal use in veno-venous pump-drive techniques. Efficiency was excellent, with urea daily clearances as high as 50 liters or more. The high permeability and porosity of the membrane also increased the clearances of larger solutes such as creatinine and inulin. No side effects occurred during treatment and we conclude that cellulose triacetate may be considered a good alternative to synthetic membranes in continuous renal replacement therapies.

Cellulose triacetate: another membrane for continuous renal replacement therapy / Ronco, C.; Brendolan, A.; Everard, P.; Irone, M.; Ballestri, M.; Cappelli, Gianni; Inguaggiato, P.; Bellomo, R.. - In: JN. JOURNAL OF NEPHROLOGY. - ISSN 1121-8428. - STAMPA. - 12:4(1999), pp. 241-247.

Cellulose triacetate: another membrane for continuous renal replacement therapy.

CAPPELLI, Gianni;
1999-01-01

Abstract

The evolution of technology and biomaterials has permitted a parallel development of renal replacement therapies in the acute, critically ill patient. From the original continuous artero-venous hemofiltration method new techniques such as continuous veno-venous hemofiltration, hemodiafiltration and high-flux dialysis have been developed and are clinically used. Similar progress has been made with artificial membranes. We investigated the possibility of using a modified cellulosic membrane for continuous therapies, assessing the hydraulic characteristics and clearance performances of high-flux cellulose triacetate hemodiafilter (0.7 m2) in vitro and in vivo. The flowdynamic characteristics of the filter suggest its optimal use in veno-venous pump-drive techniques. Efficiency was excellent, with urea daily clearances as high as 50 liters or more. The high permeability and porosity of the membrane also increased the clearances of larger solutes such as creatinine and inulin. No side effects occurred during treatment and we conclude that cellulose triacetate may be considered a good alternative to synthetic membranes in continuous renal replacement therapies.
12
4
241
247
Cellulose triacetate: another membrane for continuous renal replacement therapy / Ronco, C.; Brendolan, A.; Everard, P.; Irone, M.; Ballestri, M.; Cappelli, Gianni; Inguaggiato, P.; Bellomo, R.. - In: JN. JOURNAL OF NEPHROLOGY. - ISSN 1121-8428. - STAMPA. - 12:4(1999), pp. 241-247.
Ronco, C.; Brendolan, A.; Everard, P.; Irone, M.; Ballestri, M.; Cappelli, Gianni; Inguaggiato, P.; Bellomo, R.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/20916
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 10
social impact